AquaHeart has developed a single-shot Pulmonary Vein Isolation therapy that utilizes high-energy, short-duration ablation to treat atrial fibrillation, a condition affecting a significant portion of the population. This technology enables more cardiologists to perform heart ablations safely and efficiently, increasing access to treatment for the 90% of patients currently untreated.
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Atrial fibrillation (AFib) affects a significant portion of the population, increasing the risk of stroke. Current treatment options, such as heart ablation, are only accessible to a small percentage of patients due to the need for highly skilled electrophysiologists and specialized catheter laboratories. This limits access to potentially life-saving treatment for the majority of individuals who could benefit from it.
Solution
AquaHeart is developing a single-shot Pulmonary Vein Isolation (PVI) therapy designed to expand access to AFib treatment. Their technology aims to simplify heart ablation procedures, enabling more cardiologists to perform them safely and efficiently. The "over the wire" technique facilitates fast and safe pulmonary vein insulation, while real-time feedback reduces the need for complicated mapping procedures. By using a strictly anatomical approach, AquaHeart's technology reduces the traditional preconditions for ablative AFib therapy, making it applicable in a wider range of hospitals.
Target Audience
The primary target audience includes interventional cardiologists and hospitals seeking to expand their capabilities in treating atrial fibrillation, as well as the large population of untreated AFib patients.
Features
- Single-shot, high-energy, short-duration ablation technology for pulmonary vein isolation
- "Over the wire" technique for fast and safe application
- Real-time success feedback to guide the procedure
- Simplified procedure reduces the need for complicated mapping
- Anatomical approach lowers the barriers to entry for hospitals
- Designed to be easier to use than existing ablation technologies